Pluri Inc. (NASDAQ:PLUR) Short Interest Update

Pluri Inc. (NASDAQ:PLUR) was the target of a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 9,104 shares, a drop of 20.7% from the November 30th total of 11,486 shares. Based on an average daily volume of 54,326 shares, the short-interest ratio is currently 0.2 days. Currently, 0.1% of the shares of the company are sold short. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 54,326 shares, the short-interest ratio is currently 0.2 days.

Pluri Stock Performance

NASDAQ:PLUR opened at $3.06 on Tuesday. The stock has a 50 day simple moving average of $3.56 and a 200 day simple moving average of $4.42. The stock has a market cap of $28.31 million, a P/E ratio of -0.65 and a beta of 0.58. Pluri has a 1-year low of $2.82 and a 1-year high of $7.13. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 51.65.

Pluri (NASDAQ:PLUR) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($0.65) EPS for the quarter. Pluri had a negative net margin of 1,708.71% and a negative return on equity of 4,191.91%. The firm had revenue of $0.32 million during the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Pluri in a research note on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Pluri stock. Jane Street Group LLC acquired a new stake in shares of Pluri Inc. (NASDAQ:PLUR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 10,928 shares of the company’s stock, valued at approximately $47,000. Jane Street Group LLC owned approximately 0.14% of Pluri at the end of the most recent reporting period. 16.59% of the stock is currently owned by hedge funds and other institutional investors.

About Pluri

Pluri (NASDAQ:PLUR) is a clinical-stage biotechnology company focused on the development and manufacturing of placental-derived cell therapy products. The company’s proprietary three-dimensional microcarrier expansion platform enables large-scale, off-the-shelf production of PLX (placental expanded) cells, which are being investigated for a range of acute and chronic conditions. Pluri’s approach seeks to combine the regenerative and immunomodulatory properties of stromal cells with a scalable manufacturing process that does not require patient-specific cell harvesting.

Pluri advances its pipeline through internally funded research programs and strategic collaborations with academic institutions and government agencies.